A carregar...
A C-MET-ß1 INTEGRIN COMPLEX DRIVES INVASIVE RESISTANCE TO ANTI-ANGIOGENIC THERAPY
BACKGROUND: Anti-angiogenic therapies like bevacizumab are promising for cancer, but acquired resistance, which often includes increased invasiveness, can limit their utility. We investigated mediators of this invasive resistance using a large archive of bevacizumab-resistant glioblastoma (BRG) tiss...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4144580/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.34 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|